ConductScience.org, home

Paper19357

Classical and alternative complement pathway activation by pneumococci.

Stephens CG and 2 others. Infect Immun, 1977. Cited by 57 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Classical and alternative complement pathway activation by pneumococci. Papers, record 19357. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19357

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Classical and alternative complement pathway activation by pneumococci.
PubMed
Journal
Infect Immun
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
1.93
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stephens CGC G
2Williams RC JrR C
3Reed WPW P

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement System ProteinsMajor topic
Streptococcus pneumoniaeMajor topic
Edetic Acid
Egtazic Acid
Erythrocytes
Humans
Immunoglobulin Fc Fragments
Immunoglobulin G
Polysaccharides, Bacterial
Species Specificity
Zymosan

Source PubMed

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,936Antigenemia in fulminant pneumococcemia.Ann Intern Med1976https://conductscience.org/library/papers/5936PubMed
2234,994Maxwell Finland Lecture. Random gleanings from a life with the pneumococcus.J Infect Dis1975https://conductscience.org/library/papers/234994PubMed
3978,134Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.J Exp Med1976https://conductscience.org/library/papers/978134PubMed
41,002,987Investigations of the complement-fixing sites of immunoglobulins.J Immunol1976https://conductscience.org/library/papers/1002987PubMed
51,279,001Complement system in pneumococcal infections.Infect Immun1976https://conductscience.org/library/papers/1279001PubMed
64,139,894Possible pathogenetic role of capsular antigens in fulminant pneumococcal disease with disseminated intravascular coagulation (DIC).Am J Med1974https://conductscience.org/library/papers/4139894PubMed
74,150,446The role of immunoglobulin in the interaction of pneumococci and the properdin pathway: evidence for its specificity and lack of requirement for the Fc portion of the molecule.J Immunol1974https://conductscience.org/library/papers/4150446PubMed
84,151,106Reactions between certain strains of pneumococci and Fc of IgG.J Immunol1974https://conductscience.org/library/papers/4151106PubMed
94,181,833The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.J Exp Med1969https://conductscience.org/library/papers/4181833PubMed
104,402,312Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.J Immunol1972https://conductscience.org/library/papers/4402312PubMed
114,403,402Bactericidal and opsonic properties of C4-deficient guinea pig serum.J Immunol1972https://conductscience.org/library/papers/4403402PubMed
124,404,827Determination of antibody to pneumococcal polysaccharides with chromic chloride-treated human red blood cells and indirect hemagglutination.Appl Microbiol1972https://conductscience.org/library/papers/4404827PubMed
134,630,981Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis.J Clin Invest1973https://conductscience.org/library/papers/4630981PubMed
144,673,615Characteristics of complement fixation by aggregated IgE.J Immunol1972https://conductscience.org/library/papers/4673615PubMed
154,796,971Consumption of human complement components by complexes of IgG with protein A of Staphylococcus aureus.Immunochemistry1973https://conductscience.org/library/papers/4796971PubMed
164,811,964Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly.J Immunol1974https://conductscience.org/library/papers/4811964PubMed
174,846,468Serum factors responsible for killing of Shigella.Immunology1974https://conductscience.org/library/papers/4846468PubMed
184,956,917Immunochemical quantitation of antigens by single radial immunodiffusion.Immunochemistry1965https://conductscience.org/library/papers/4956917PubMed
195,117,668Dual pathways of complement interaction with guinea pig immunoglobulins.J Immunol1971https://conductscience.org/library/papers/5117668PubMed
205,358,347Immunoglobulin peptide with complement fixing activity.Nature1969https://conductscience.org/library/papers/5358347PubMed

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
22,415,003Death is associated with complement C3 depletion in cerebrospinal fluid of patients with pneumococcal meningitis.mBio2012https://conductscience.org/library/papers/22415003PubMed
10,456,894Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.Infect Immun1999https://conductscience.org/library/papers/10456894PubMed
8,168,944Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae.Infect Immun1994https://conductscience.org/library/papers/8168944PubMed
7,429,626Effect of intravenously injected killed pneumococci on leukocytes, complement, and phagocytosis in rabbits.Infect Immun1980https://conductscience.org/library/papers/7429626PubMed
7,263,061Reduction of circulating granulocytes induced by type 1 pneumococcal cell walls in New Zealand white rabbits.Infect Immun1981https://conductscience.org/library/papers/7263061PubMed
7,216,447Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.Infect Immun1981https://conductscience.org/library/papers/7216447PubMed
7,007,217Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.Immunology1980https://conductscience.org/library/papers/7007217PubMed
6,995,341Activation of the alternative pathway of complement by mycobacteria and cord factor.Infect Immun1980https://conductscience.org/library/papers/6995341PubMed
6,901,703Complement activation by Coccidioides immitis: in vitro and clinical studies.Infect Immun1980https://conductscience.org/library/papers/6901703PubMed
6,802,760Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.Infect Immun1982https://conductscience.org/library/papers/6802760PubMed
6,403,465Granulocyte phagocytosis of Streptococcus pneumoniae in properdin-deficient serum.Infect Immun1983https://conductscience.org/library/papers/6403465PubMed
6,354,922Opsonization of various capsular (K) E. coli by the alternative complement pathway.Immunology1983https://conductscience.org/library/papers/6354922PubMed
6,286,493Gram-positive bacteria-induced granulocytopenia and pulmonary leukostasis in rabbits.Infect Immun1982https://conductscience.org/library/papers/6286493PubMed
3,700,607Relationships between alternative complement pathway activation, C-reactive protein, and pneumococcal infection.J Clin Microbiol1986https://conductscience.org/library/papers/3700607PubMed
2,195,989Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.Antonie Van Leeuwenhoek1990https://conductscience.org/library/papers/2195989PubMed
478,640Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis.Infect Immun1979https://conductscience.org/library/papers/478640PubMed
102,478Complement activity in middle ear effusions.Clin Exp Immunol1978https://conductscience.org/library/papers/102478PubMed
38,742Bactericidal and bacteriostatic action of chloramphenicol against memingeal pathogens.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/38742PubMed
37,161Interaction of pneumococcal antigens with complement in rats.Infect Immun1979https://conductscience.org/library/papers/37161PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19357

GET https://conductscience.org/api/papers/v1/19357/authors